Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Effect of the tumor promoter 12-0-tetradecanoylphorbol-13-acetate on. cap alpha. -aminoisobutyrate uptake in friend erythroleukemic cells

Journal Article · · Cancer Res.; (United States)
OSTI ID:5474228
In Friend erythroleukemic cells, the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) increases the rate of influx as well as the steady-state accumulation of the amino acid transport probe ..cap alpha..-aminoisobutyric acid (AIB). This non-metabolizable analog is concentrated in these cells by utilizing the energy of the Na/sup +/ electrochemical gradient. The effect of TPA is to increase the ouabain-sensitive component of uptake of AIB (and of the K/sup +/ analog /sup 86/Rb/sup +/). Transport changes are not observed until 30 min after application of the promoter and reach a maximum in about 6 hr. The effects are blocked by cycloheximide. The flux results are consistent with a model in which the membrane potential is increased and, with it, the driving force on the coupled Na/sup +/-AIB movement. The effect is possible mediated by a change in electrogenicity of the Na:K pump. TPA raises the steady-state accumulation levels of AIB. By altering external K/sup +/ in the presence of valinomycin, the membrane potential may be adjusted and, with it, the accumulation of AIB. Over a wide range of membrane potentials, TPA-treated cells accumulate more AIB than do controls, suggesting a possible change in the internal Na/sup +/ activity.
DOE Contract Number:
W-7405-ENG-26
OSTI ID:
5474228
Journal Information:
Cancer Res.; (United States), Journal Name: Cancer Res.; (United States) Vol. 41; ISSN CNREA
Country of Publication:
United States
Language:
English